retatrutide type 2 diabetes trial 2024 Availability & Timeline Phase 2 Trial of Retatrutide

Rules vary by state and federal guidance for controlled substances

At the highest dose of 12 mg retatrutide, the average weight loss after 48 weeks was 24.2% with reduction up to 30% from the baseline weight in 25% of participants

The GLP-1R is a G-protein coupled receptor that has wide tissue expression, including in the brain, the wall of the portal vein near the hilus of the liver, and arteries and arterioles from various organs (kidney, heart, pancreas, and intestine) [18]

GLP-1 Injection is a weight loss injection that mimics glucagon-like peptide (GLP-1), making you feel fuller faster after you eat

Birth control pills may not work as well while using Zepbound

As the initial excitement fades, investors and patients alike are asking harder questions: Do these platforms deliver measurable, sustained health outcomes